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Abstract 
Research has demonstrated that a substantial subset of individuals experiencing uncontrollable 
worry, a hallmark symptom of generalized anxiety disorder (GAD), paradoxically have good capacity for 
top-down control over their thoughts. However, why individuals with good cognitive control worry 
excessively remains unclear. Research showing that positive beliefs about worry set those experiencing 
pathological worry apart from healthy controls, offers a possible explanation. Individuals with good 
capacity for cognitive control may intentionally engage in worry because they hold beliefs that it is 
adaptive to do so. This study tested this hypothesis using an objective index of cognitive control capacity 
(resting heart rate variability [HRV]). Questionnaire measures of generalized anxiety disorder symptom 
severity and beliefs about worry were administered and heart rate variability, as an objective measure of 
cognitive control, was measured in a sample of 109 undergraduate students at The Ohio State University 
(ages 18-28, M = 19.3, SD = 2.1, 65.1% female). Consistent with expectation, regression analyses 
revealed that positive beliefs about worry largely moderated the association between heart rate variability 
and pathological worry. The general pattern showed that individuals with high levels of HRV tended to 
report experiencing high GAD symptom severity when they strongly endorsed positive beliefs about 
worry. This indicates that such individuals at least initiate worry intentionally, although questions remain 
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Though generalized anxiety disorder (GAD) is relatively common and shown to be 
persistent over a lifetime, (with a 4.3% lifetime prevalence rate; Kessler et al., 2012) there is less 
research surrounding GAD than other anxiety and mood disorders. Furthermore, current 
treatments for GAD, such as cognitive-behavioral therapy (CBT) tend to be less effective than 
treatments for other disorders. In a meta-analysis by Cuijpers et al. (2014) it was demonstrated 
that CBT is effective in treating less than 50% of patients. The present research aims to elucidate 
physiological and motivational factors that may play a role in the development and maintenance 
of GAD in order to aid future treatment protocols.  
GAD) is characterized by persistent, unmanageable, excessive worry regarding aspects of 
everyday life (Hoyer, Becker, and Roth, 2001). Such pathological worry is often associated with 
heightened levels of autonomic arousal (AA). Autonomic arousal includes symptoms such as dry 
mouth, shortness of breath, and increased heart rate. However, the extent to which AA symptoms 
accompany worry varies widely and appears to depend on the worrier’s capacity for top-down 
control over their thoughts (Vasey, Chriki, & Toh, 2017; Toh and Vasey, 2017).  
One theory highlighting the role of AA in pathological worry is the Cognitive Avoidance 
Model (Borkovec et al., 2004). This theory posits that individuals who experience pathological 
worry utilize their ability to shift these thoughts to a verbal-linguistic mode of processing (i.e., 
thinking in terms of words), rather than imaginal processing (i.e., thinking in terms of visual 
scenes). This serves to allow chronic worriers to suppress the AA symptoms triggered by 
threatening visual images, which negatively reinforces the verbal-linguistic mode of processing. 
A second model from Newman and Llera (2011), the Contrast Avoidance Model, suggests 
pathological worriers maintain a consistent state of heightened AA. This is used as mechanism to 
avoid aversive shifts from euthymic to anxious mood states when a potential threat actually 
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occurs. In this way, persistent worry is reinforced as a strategy to avoid such aversive spikes in 
emotion and instead maintain a constant emotional and physiological state.  
These theories fail, however, to account for the heterogeneity in the levels of autonomic 
arousal seen amongst the GAD population. For example, Andor and colleagues (2008) observed 
no significant difference in heart rate between individuals with GAD and healthy control subjects 
at baseline. Similarly, Hohen-Saric and McLeod (2000) found that GAD patients, while self-
reporting heightened AA, did not exhibit a higher heart rate than controls under non-specific 
stress conditions. This pattern was also found in a study utilizing skin conductance responses as a 
measure of AA (Fisher, Granger, and Newman, (2009). Conversely, results from Knepp and 
Friedman (2008) indicate that subjects considered high in worry exhibit increased heart rate 
across baseline and induced worry conditions. Increased mean heart rate for individuals with 
GAD was also found in a four-day ambulatory study conducted by Hoehn-Saric and colleagues 
(2004).  
Vasey et al. (2017) have drawn attention to this heterogeneity in autonomic arousal 
symptoms and propose their Cognitive Control Model to account for it. In this model, the 
heterogeneity in AA within samples of chronic worriers can be explained by considering 
individual differences in cognitive control capacity across such samples. This model posits that 
persons with high levels of pathological worry must possess good capacity for cognitive control 
if they are to suppress autonomic arousal by constraining worry to a verbal mode of processing. 
Those lacking the capacity to do so must instead process potential threats imaginally, resulting in 
heightened AA. Vasey and colleagues have amassed substantial evidence supporting this model. 
For example, Vasey et al. (2017) showed that GAD symptom severity significantly predicted 
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symptoms of AA only when cognitive control capacity was low. This was true even in an analog 
GAD sample.   
Thus far, the question as to why individuals with good cognitive control capacity would 
paradoxically report experiencing excessive and uncontrollable worry remains unanswered. One 
possible explanation may lie in beliefs about the function of worry. Borkovec and Roemer 
(1995) propose that worriers may believe worry serves an adaptive function and thus may initiate 
worry intentionally. Since feared outcomes rarely happen, worry may serve as a coping strategy 
that is negatively reinforced by virtue of this fact. Specifically, six possible reasons for worry 
were identified among the GAD population. First, worry may enhance motivation to complete 
tasks. Second, worry may aid in problem-solving. Third, worry may help them prepare for the 
worst. Fourth, worry may aid in planning to avoid negative events. Fifth, worry may serve to 
distract from more anxiety-provoking topics, Lastly, worriers may hold superstitious beliefs that 
worry will influence the likelihood of future events. Borkovec and Roemer (1995) showed that 
the motivation, preparation, and prevention reasons were consistently more highly endorsed by 
GAD subjects than both non-anxious and non-worried anxious individuals.  
Similarly, Freeston and colleagues (1994) have also proposed that individuals with GAD 
may have primary adaptive motivations to worry. Specifically, they may believe that worry has 
positive effects (e.g., enhanced problem-solving) and worry prevents negative outcomes. Persons 
with GAD scored more highly on both of these measures than their non-clinical counterparts. 
These results indicate that persons with GAD may view worry as beneficial rather than 
maladaptive. In addition to these findings, research conducted by Iijima and Tanno (2013) 
showed that worry in response to stressful events was highest when individuals endorsed positive 
beliefs about worry. In a sample of children, Kerts and Woodruff-Borden also demonstrated that 
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positive beliefs about worry distinguished clinical participants from non-clinical on measures of 
worry.  
Holding the beliefs that worry serves positive functions may partially account for the 
treatment resistance exhibited in patients with GAD. Therefore, addressing these reasons may be 
a key step in treating GAD. In support of this, Westra, Arkowitz, and Dozois (2009) found that 
adding the pre-treatment of motivational interviewing to cognitive-behavioral therapy helped 
significantly reduce endorsement of worry in GAD patients. Motivational interviewing was 
designed to decrease ambivalence about letting go of these positive beliefs about worry. 
However, more research is needed surrounding the effects of motivation behind worry on GAD 
symptom severity. 
The present study aims to use an objective measure of cognitive control, resting heart rate 
variability (HRV). HRV represents high-frequency variability in the intervals between 
heartbeats. High HRV is hypothesized to characterize parasympathetic inhibitory control over 
the sympathetic autonomic nervous system and is primarily mediated by the vagus nerve. 
Previous research indicates HRV is positively correlated with measures of cognitive control 
(Holzman and Bridgett, 2016). For example, HRV has also been shown to correlate with 
enhanced activity in areas of the brain hypothesized to mediate cognitive control capacity, such 
as the prefrontal cortex (Jennings et al., 2016). Additionally, high heart rate variability has been 
associated with superior performance on tasks measuring executive functioning (Thayer et al., 
2009). Thayer and Lane (2000) have proposed that disruptions in this parasympathetic control 
may lead to affective and or cognitive problems such as GAD. Additionally, findings from Free 
(2017) demonstrate that symptoms of autonomic arousal are rated more highly among high 
worriers when HRV is low, a pattern consistent with the Cognitive Control Model. Taken 
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together, these studies provide increasing evidence for HRV as an objective measure of cognitive 
control capacity.  
A meta-analysis by Chalmers et al. (2014) suggests that individuals with GAD tend to 
have lower heart rate variability than controls. However, this pattern has failed to replicate in 
some instances. In a study using a clinical sample of GAD patients Hammel et al. (2010) found 
no differences in HRV between individuals with GAD and controls on any task condition. 
Research by Kollai and Kollai (1992) utilizing an invasive pharmacological method of 
measuring vagal tone also failed to find differences in HRV between clinical GAD subjects and 
controls. Furthermore, findings from a meta-analysis by Holley, (2017) found the difference in 
resting HRV between GAD samples and healthy controls was modest. Consistent with the 
Cognitive Control Model, these results indicate that a subset of individuals with GAD may 
possess the cognitive control capacity necessary to suppress autonomic arousal. However, the 
question of why they use this ability maladaptively to devote their attention to worrying rather 
than shifting attention away from negatively arousing stimuli remains. The heterogeneity in the 
literature surrounding heart rate variability indicates there may be influential factors in need of 
further investigation.  
The present study aims to determine if individual differences positive beliefs about worry 
moderate the association between HRV and GAD symptom severity. I predict that resting HRV 
will be significantly negatively correlated with GAD symptom severity only when it is low. 
When positive beliefs about worry are high, HRV should be associated with high GAD 
symptoms.  
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Method 
Participants and Procedure: 
 Participant data for this thesis was taken from a prior study conducted by Chriki (2015). 
Participants were recruited through the Research Experience Program (REP) at The Ohio State 
University. The total sample was comprised of 123 participants who completed two laboratory 
sessions separated by 1-2 weeks. However, due to participant drop-out only data for the first 
session will be used for the purpose of this thesis. The present study utilizes data from 109 
participants who completed the first session and who had useable HRV data. The full sample 
could not be used due to missing data for some participants. From the sample, 65.1% self-
identified as female and participants ranged in age from 18-28 (M = 19.3, SD = 2.1). The sample 
was primarily Caucasian (71.6%, African American: 7.3%, Asian American: 6.4%, Latino: 
3.7%, Mixed Ethnicity: 5.5%, Other Ethnicity: 5.5%). All participants received credit in their 
Introduction to Psychology course for their participation.  
Self-Report Questionnaires: 
Generalized Anxiety Disorder Questionnaire – IV (GADQ-IV): Severity of GAD 
symptoms was assessed using the GADQ-IV, a self-report measure containing all diagnostic 
criteria for GAD based on the Diagnostic and Statistical Manual of Mental Disorders, 4th edition. 
The GADQ-IV is comprised of five yes/no questions that assess frequency and duration of 
excessive and uncontrollable worry, two items regarding how interfering and distressing worry is 
as well as physical symptoms, a checklist of symptoms commonly associated with worry, and a 
open-ended section in which topics of most frequent worry are listed. The GADQ-IV has been 
shown to have good agreement with structured clinical interviews (kappa of 0.67) as well as 83% 
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sensitivity and 89% specificity. Furthermore, this questionnaire has demonstrated good test-retest 
reliability and both convergent and discriminant validity (Newman et al., 2002).  
Reasons to Worry Questionnaire (RWQ): The Reasons to Worry Questionnaire is a 6-
item self-report questionnaire with subscales assessing reasons why subjects may worry 
(Borkovec and Roemer, 1995). Questions classify reasons to worry as serving the following 
functions: motivation to complete tasks, aids in problem solving, preparation for negative events, 
avoidance of negative events, distraction from emotional topics, and superstitious effects on 
possible outcomes. Subjects are asked to indicate how much they feel each item applies to them. 
Items are rated on a 5-point Likert scale ranging from “not at all” to “very much”. GAD status 
correlates with higher scores on each of the six items (Borkovec and Roemer, 1995). 
Why Worry? Questionnaire: The Why Worry? Questionnaire is a 20-item self-report 
measure in which individuals indicate the motivation behind their worry (Freeston et al., 1994). 
Items are classified in two categories: worry prevents negative outcomes (e.g. “I worry in order 
to avoid disappointment”) and worry has positive effects (e.g. “By worrying I can stop bad 
things from happening”). Each item requires subjects to judge how characteristic the statement is 
of them and is rated on a 5-point Likert scale ranging from “not at all characteristic of me” to 
“entirely characteristic of me”. For purposes of this experiment, a total score was used rather 
than subscale scores. Freeston et al. (1994) demonstrated the Why Worry? Questionnaire has 
good agreement with other measures used to assess worry as well as inter-item consistency 
(Chronbach’s α = 0.88 in the current sample). Results from Freeston et al. (1994) also show good 
discriminant validity and ability to distinguish pathological worriers from healthy controls.   
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Measures of Cognitive Control Capacity: 
 Heart Rate Variability (HRV): Five-minute periods of resting HRV were collected 
shortly after participants arrived for Session 1. To collect this physiological data the MindWare 
2000D Impedance Cardiograph package was used. The package uses a 14 bit A/D converter with 
a maximum sample rate of 48k samples/second. This yielded an inter-beat interval time series 
(IBI),. Analysis of the data was performed using MindWare Technologies Signal Processing 
Applications. The index of HRV used in this study was the root-mean squares of successive 
differences (RMSSD), which is widely used in HRV research. 
Results 
Preliminary Analyses  
 All analyses were conducted with complete data from 109 participants (88.6% of the 
original data set). Descriptive statistics and correlations for all variables are included in Table 1. 
In order to test if the excluded data from the original 123 participants significantly affected the 
results for the present study, a Little’s Missing Completely at Random (LMCAR) analysis was 
conducted. A chi-squared test revealed that participants were not removed from the study 
systematically (p = 0.240). It can therefore be concluded that exclusion of participants with 
incomplete data sets did not influence the present research.  
Data Analytic Strategy 
To increase reliability and reduce Type I error rate, a composite score of the WW and 
RWQ was created and used for the primary test of this study’s prediction. Creation of the 
composite score consisted of converting raw scores of both questionnaires to z-scores in Step 1. 
In Step 2, the z-scores were averaged. The aforementioned hypothesis was tested using multiple 
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linear regression (MLR) analyses. MLR analyses involved two hierarchical steps. Specifically, to 
predict GAD symptom severity, positive beliefs about worry and heart rate variability were 
added in step 1. In Step 2, the interaction HRV x Beliefs was added. All models were tested 
using PROCESS for SPSS, which was also used to interpret interactions. Significant interactions 
were illustrated with predicted lines at one SD above and below the mean for the measure of 
beliefs about worry. 
Prediction: HRV x Beliefs predict GAD symptom severity 
Composite of RWQ and WW 
As shown in Table 2, the overall model for predicting GAD symptom severity was 
significant (R² = 0.342, p < 0.001). The interaction term for the composite score of the RWQ and 
WW questionnaire was significant (sr = 0.18, p = 0.001). As shown in Figure 1, GAD symptom 
severity was significantly predicted by HRV when composite scores were low (B = -1.54, p = 
0.002), but not high (B = 0.30, p = 0.47).  Examination of the regions of significance showed that 
HRV was negatively correlated with GAD symptom severity when the Worry Beliefs Composite 
score was less than  -0.78 SDs below its average. In contrast, HRV was significantly positively 
correlated with GAD symptom severity when the Worry Beliefs Composite score was greater 
than 1.68 SDs above its average.   
 RWQ 
As shown in Table 3, the overall model for predicting GAD symptom severity from HRV 
and the Reasons for Worry Questionnaire was significant (R²= 0.219, p < 0.001). The interaction 
term, HRV x Beliefs, was also significant (p < 0.001), showing that the magnitude of the 
association between HRV and GAD symptom severity depended on level of positive beliefs 
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about worry (See Figure 2). The GAD x HRV interaction accounted for nearly 9% of variance in 
GAD symptom severity (ΔR² = 0.088 p < 0.001). Examination of the regions of significance 
using PROCESS revealed that HRV was significantly negatively correlated with GAD symptom 
severity when RWQ scores were less than 13.67. In contrast, HRV was significantly positively 
correlated with GAD symptom severity when RWQ scores were greater than 19.91.  
Because Borkovec and Roemer (1995) found that certain items on the RWQ accounted 
for significantly more of the variance between GAD samples and control samples, regression 
analyses were run on the RWQ’s individual items. Results revealed that several of the items 
individually influenced the magnitude of the association between HRV and GAD symptom 
severity. As shown in Table 4, for item 2 “Worry is an effective way to problem-solve” the 
overall regression was not significant. However, as shown by Figure 4, the HRV x Item 2 
interaction was significant (sr = .19, p = 0.047). As shown in Table 5, the overall regression for 
item 4 “If I worry about something, I am more likely to actually figure out how to avoid or 
prevent something bad from happening” was significant (R² = 0.381, p < 0.001) As illustrated in 
Figure 5, the Item 4 x HRV interaction was significant (sr = .32, p = .001. As shown in Table 6, 
the model for item 5, “Worrying about most of the things I worry about is a way to distract 
myself from worrying about even more emotional things” was also significant (R² = 0.216, p < 
0.001). As shown in Figure 6, the Item 5 x HRV interaction was significant (sr = .29, p = .001) 
and accounted for over 8% of score variance (ΔR² = 0.087). Analyses for item 1, “Worry helps to 
motivate me to get things done that I need to get done”, item 3, “If  I worry about something, 
when something bad does happen, I’ll be better prepared”, and item 6, “Although it may not 
actually be true, it feels like if I worry about something, the worrying makes it less likely that 
something bad will happen” did not yield a significant interaction terms.  
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WW 
A preliminary analysis revealed one high influence outlier (standardized DFFITS = 1.01). 
With that case included the overall model for predicting GAD symptom severity was significant 
(R² = 0.417, p < 0.001). However, the interaction term did not reach significance. With the high 
influence case dropped results remained unchanged. However, it should be noted that although 
the Why Worry x HRV interaction did not achieve significance (sr = .10, p = .195), the pattern of 
the interaction was as expected. However, whereas HRV was not significantly associated with 
GAD symptom severity at any level of positive beliefs about worry, such beliefs were 
significantly positively associated with GAD symptom except when HRV was low (i.e., 
LnRMSSD < 1.59). 
Discussion 
Research has shown that a certain subset of individuals with generalized anxiety disorder 
exhibit good cognitive control capacity (Vasey, Chriki, and Toh 2017). However, the reason 
behind why these individuals devote their attention to worry is unclear. Holding positive beliefs 
about worry may serve as a possible explanation to this paradox. Studies have demonstrated that 
individuals with GAD tend to endorse positive beliefs about worry more than their non-clinical 
counterparts (Freeston et al., 1994, Borkovec and Roemer, 1995). Therefore, I hypothesized that 
the association between HRV and GAD would be moderated by positive beliefs about worry.   
Results from this study were largely consistent with this hypothesis. Heart rate variability 
interacted with a composite measure of beliefs about worry to predict GAD symptom severity as 
measured by the GADQ-IV. For the composite measure as well as the total score on the RWQ 
and three of its items, the pattern found was such that high levels of HRV were most strongly 
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negatively associated with GAD symptom severity among individuals holding high levels of 
beliefs that worry adaptive. At lower levels of such beliefs, HRV was significantly negatively 
associated with GAD symptoms. This suggests that individuals with high cognitive control 
capacity (i.e., high HRV) are not protected from high levels of GAD symptoms when they 
believe worry is adaptive.  
Like the composite measure, the RWQ total score produced a significant interaction. 
However, the positive beliefs on the RWQ differed in their magnitude of their association with 
GAD and HRV. Specifically, the beliefs that worry aids in problem solving (Item 2), worry helps 
prepare for negative events (Item 4), and worry distracts for more emotional topics (Item 5) 
carried a large portion of the variance in this sample. This pattern is consistent with findings 
from Borkovec and Roemer (1995), who found that items 2 and 4 most distinguished a GAD 
sample from non worried-anxious and healthy control groups. It is interesting to note that the 
interaction involving item 4 accounted for the largest percentage of variance in GAD symptom 
severity. Item 4 was the only item to significantly differentiate those with GAD from controls in 
both of Borkovec and Roemer’s samples. This item shows most clearly that higher levels of 
HRV are significantly associated with greater GAD symptom severity among those holding such 
a belief.   
These results indicate that although individuals high in heart rate variability possess the 
ability to direct their attention away from worry, their belief that worry serves positive functions 
may play a role in the maintenance of GAD. However, is important to consider why the 
interaction between GAD and HRV was not significant on the Why Worry? Questionnaire alone. 
One explanation for this is suggested by the fact that scores on the Why Worry Questionnaire 
were much strongly correlated with GAD symptom severity (zero-order r = .65) than were scores 
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on the Reasons to Worry Questionnaire (r = .36). Consequently, there was much less room for 
individual differences in HRV to make a difference. This would make it particularly difficult to 
detect an interaction as the variance in the product term representing the interaction was 
constrained. It should be noted however, that the interaction did match the pattern found for the 
composite and the Reasons to Worry Questionnaire alone. However, it is unclear why the Why 
Worry? Questionnaire was so much more strongly correlated with GAD symptoms severity than 
the Reasons to Worry Questionnaire. It appears that the latter questionnaire may be more 
sensitive to differences in beliefs among high worriers than the latter measure. 
In summary, this study’s results largely support the prediction that high levels of 
cognitive control are most likely to be associated with GAD symptoms among individuals who 
believe that worry has adaptive value. Surprisingly, high levels of cognitive control do now 
appear to protect such individuals from their worries becoming excessive and uncontrollable. 
Limitations and Future Directions 
The present research has several limitations that should be taken into consideration when 
interpreting the results. Firstly, power to detect interactions is relatively low in small samples. 
With a sample size of 109 participants, this study likely lacked the power necessary to detect 
some interactions. This is salient in the case of the Why Worry? Questionnaire, since its stronger 
correlation with GAD symptoms than the Reasons to Worry Questionnaire also reduces power 
due to restrictions on the range of the product term representing its interaction with cognitive 
control. Generalizability of these results may also be limited given the constrained age range as 
well as lack of ethnic diversity among participants. Generalizability may be further limited by 
the fact that all participants were college students. Furthermore, causality cannot be determined 
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from this study given its cross-sectional design. Results from this study do, however, warrant 
further investigation with a larger and more representative sample.  
While this study provides valuable insights, the accuracy of these positive belief about 
worry endorsed by individuals with GAD should be investigated. In other words, whether these 
beliefs actually aid individuals in the domain they are believed to. Future studies should also 
address why GAD individuals develop these positive beliefs about worry.  Lastly, application of 
these findings should be investigated in the context of motivational interviewing for GAD 
individuals. Addressing these positive beliefs about worry in a clinical setting may be an 
important step in the treatment process, and a lack thereof may be involved in the treatment-
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Table 1 
Variable 1 2 3 4 M SD 
1. GADQ-IV - -.018 0.361 0.643 3.36 3.69 
2. HRV  - .037 -.051 3.58 0.98 
3. RWQ   - 0.651 14.39 5.08 
4. WW    - 49.55 16.12 
Note: N = 109. Bold correlations are significant at p < 0.01. GADQ-IV = Generalized Anxiety 
Disorder Questionnaire-IV total score, HRV = Heart Rate Variability, RWQ = Reasons for 
Worry Questionnaire, WW = Why Worry? Questionnaire 
Table 2 
Predicting GAD symptom severity from Composite Worry Beliefs scores and HRV 
                                    R²               ΔR²            Semi-Partial             B (SE)             p-value 
DV: GADQ-IV        0.34                                                                                               < 0.001 
Constant                                                                                            7.52 (1.17)           < 0.001 
HRV                                                                       -0.07                  -0.29 (0.315)           0.361 
RWQ                                                                      -0.06                   -1.23 (1.57)            0.436 
HRV x RWQ                                 0.088                 0.18                   0.96 (0.42)             0.023 
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Table 3 
Predicting GAD symptom severity from RWQ scores and HRV 
                                    R²               ΔR²            Semi-Partial             B (SE)             p-value 
DV: GADQ-IV        0.22                                                                                               < 0.001 
Constant                                                                                         18.07 (4.63)           < 0.001 
HRV                                                                       -0.29                 -4.22 (1.24)              0.001 
RWQ                                                                      -0.21                    -0.68 (.28)             0.018 
HRV x RWQ                                 0.088                 0.30                    0.26 (.07)              0.001 
 
Table 4 
Predicting GAD symptom severity from RWQ Item 2 scores and HRV 
                                    R²               ΔR²            Semi- Partial            B (SE)             p-value 
DV: GADQ-IV        0.048                                                                                               0.155 
Constant                                                                                           10.58 (2.79)         < 0.001 
HRV                                                                      -0.18                    -1.42 (0.77)            0.486 
RWQ2                                                                   -0.15                    -1.57 (1.02)         < 0.001 
HRV x RWQ2                            0.037                  0.19                      0.56 (0.28)            0.056 
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Table 5 
Predicting GAD symptom severity from RWQ Item 4 scores and HRV 
                                      R²               ΔR²            Semi-Partial             B (SE)             p-value 
DV: GADQ-IV          0.14                                                                                              < 0.001 
Constant                                                                                          16.35 (3.60)           < 0.001 
HRV                                                                       -0.36                 -3.17 (0.95)               0.001 
RWQ4                                                                    -0.26                 -3.36 (1.19)               0.005 
HRV x RWQ4                                0.10                 0.32                  1.08 (0.31)               0.001 
 
Table 6 
Predicting GAD symptom severity from RWQ Item 5 scores and HRV 
                                     R²               ΔR²            Semi-Partial            B (SE)             p-value 
DV: Item 5                0.22                                                                                          < 0.001 
Constant                                                                                         12.81 (2.64)        < 0.001 
HRV                                                                       -0.28                 -2.31 (0.70)           0.001 
RWQ5                                                                    -0.21                 -3.07 (1.25)           0.016 
HRV x RWQ5                              0.087                 0.29                    1.10 (0.32)          0.001 
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Table 7 
Predicting GAD symptom severity from WW scores and HRV 
                                     R²               ΔR²            Semi-Partial            B (SE)             p-value 
DV: GADQ-IV         0.42                                                                                             < 0.001 
Constant                                                                                          6.54 (0.27)           < 0.001 
HRV                                                                      -0.06                -0.26 (0.29)             0.386 
WW                                                                        0. 64                 2.34 (0.27)            < 0.001 
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Figure 1. HRV predicting GAD symptom severity at varying levels of the Composite score.  
 
 
















R2 = 0.585, p < 0.001













ΔR² = 0.0877, p < 0.001
R² = 0.219, p < 0.001 
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Figure 4. HRV predicting GAD symptom severity at varying levels of RWQ Item 2 scores. 
 
 


























R² = 0.1453, p < 0.001
ΔR² = 0.099, p < 0.001
R² = 0.484, p = 0.155 
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  R² = 0.216, p < 0.001 
ΔR² = 0.087, p < 0.001 
